{"id":"https://openalex.org/W3021675475","doi":"https://doi.org/10.1126/sciadv.aax7881","title":"Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti\u2013PD-1/PD-L1 immunotherapy","display_name":"Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti\u2013PD-1/PD-L1 immunotherapy","publication_year":2020,"publication_date":"2020-04-29","ids":{"openalex":"https://openalex.org/W3021675475","doi":"https://doi.org/10.1126/sciadv.aax7881","mag":"3021675475","pmid":"https://pubmed.ncbi.nlm.nih.gov/32494661","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7190323"},"language":"en","primary_location":{"id":"doi:10.1126/sciadv.aax7881","doi":"https://doi.org/10.1126/sciadv.aax7881","is_oa":true,"landing_page_url":"https://doi.org/10.1126/sciadv.aax7881","pdf_url":"https://advances.sciencemag.org/content/advances/6/18/eaax7881.full.pdf","source":{"id":"https://openalex.org/S2737427234","display_name":"Science Advances","issn_l":"2375-2548","issn":["2375-2548"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Advances","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://advances.sciencemag.org/content/advances/6/18/eaax7881.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003314533","display_name":"Muhammad Zaeem Noman","orcid":"https://orcid.org/0000-0002-1837-3097","observed_orcids":["https://orcid.org/0000-0002-1837-3097"]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Muhammad Zaeem Noman","raw_affiliation_strings":["Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":"https://orcid.org/0000-0002-1837-3097","affiliations":[{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055590804","display_name":"Santiago Parpal","orcid":"https://orcid.org/0000-0003-2861-0516","observed_orcids":["https://orcid.org/0000-0003-2861-0516"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210104651","display_name":"Sprint Bioscience (Sweden)","ror":"https://ror.org/01fbez228","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210104651"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Santiago Parpal","raw_affiliation_strings":["Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden","Sprint Bioscience, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-2861-0516","affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Sprint Bioscience, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210104651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045743708","display_name":"Kris Van Moer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Kris Van Moer","raw_affiliation_strings":["Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069638247","display_name":"Malina Xiao","orcid":"https://orcid.org/0000-0002-4157-6538","observed_orcids":["https://orcid.org/0000-0002-4157-6538"]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Malina Xiao","raw_affiliation_strings":["Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":"https://orcid.org/0000-0002-4157-6538","affiliations":[{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051523773","display_name":"Yasmin Yu","orcid":"https://orcid.org/0000-0002-0560-5012","observed_orcids":["https://orcid.org/0000-0002-0560-5012"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210104651","display_name":"Sprint Bioscience (Sweden)","ror":"https://ror.org/01fbez228","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210104651"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Yasmin Yu","raw_affiliation_strings":["Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden","Sprint Bioscience, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-0560-5012","affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Sprint Bioscience, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210104651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085233318","display_name":"Tsol\u00e8re Arakelian","orcid":"https://orcid.org/0000-0002-0079-9268","observed_orcids":["https://orcid.org/0000-0002-0079-9268"]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Tsolere Arakelian","raw_affiliation_strings":["Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102969796","display_name":"Jenny Viklund","orcid":"https://orcid.org/0000-0002-4087-9721","observed_orcids":["https://orcid.org/0000-0002-4087-9721"]},"institutions":[{"id":"https://openalex.org/I4210104651","display_name":"Sprint Bioscience (Sweden)","ror":"https://ror.org/01fbez228","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210104651"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jenny Viklund","raw_affiliation_strings":["Sprint Bioscience, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-4087-9721","affiliations":[{"raw_affiliation_string":"Sprint Bioscience, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210104651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041516398","display_name":"Angelo De Milito","orcid":"https://orcid.org/0000-0003-2591-2914","observed_orcids":["https://orcid.org/0000-0003-2591-2914"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210104651","display_name":"Sprint Bioscience (Sweden)","ror":"https://ror.org/01fbez228","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210104651"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Angelo De Milito","raw_affiliation_strings":["Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden","Sprint Bioscience, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-2591-2914","affiliations":[{"raw_affiliation_string":"Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Sprint Bioscience, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210104651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078121805","display_name":"Meriem Hasmim","orcid":"https://orcid.org/0000-0002-7920-2443","observed_orcids":["https://orcid.org/0000-0002-7920-2443"]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Meriem Hasmim","raw_affiliation_strings":["Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009759742","display_name":"Martin E. Andersson","orcid":"https://orcid.org/0009-0001-5999-5482","observed_orcids":["https://orcid.org/0009-0001-5999-5482"]},"institutions":[{"id":"https://openalex.org/I4210104651","display_name":"Sprint Bioscience (Sweden)","ror":"https://ror.org/01fbez228","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210104651"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Martin Andersson","raw_affiliation_strings":["Sprint Bioscience, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sprint Bioscience, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210104651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009482043","display_name":"Ravi K. Amaravadi","orcid":"https://orcid.org/0000-0002-5768-2474","observed_orcids":["https://orcid.org/0000-0002-5768-2474"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi K. Amaravadi","raw_affiliation_strings":["Department of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038359667","display_name":"Jessica Martinsson","orcid":"https://orcid.org/0000-0003-3834-555X","observed_orcids":["https://orcid.org/0000-0003-3834-555X"]},"institutions":[{"id":"https://openalex.org/I4210104651","display_name":"Sprint Bioscience (Sweden)","ror":"https://ror.org/01fbez228","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210104651"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jessica Martinsson","raw_affiliation_strings":["Sprint Bioscience, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-3834-555X","affiliations":[{"raw_affiliation_string":"Sprint Bioscience, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210104651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042997291","display_name":"Guy Berchem","orcid":"https://orcid.org/0000-0003-0157-2257","observed_orcids":["https://orcid.org/0000-0003-0157-2257"]},"institutions":[{"id":"https://openalex.org/I162487826","display_name":"Centre Hospitalier de Luxembourg","ror":"https://ror.org/03xq7w797","country_code":"LU","type":"healthcare","lineage":["https://openalex.org/I162487826"]},{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":true,"raw_author_name":"Guy Berchem","raw_affiliation_strings":["Department of Hemato-Oncology, Centre Hospitalier du Luxembourg, Luxembourg City, Luxembourg","Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":"https://orcid.org/0000-0003-0157-2257","affiliations":[{"raw_affiliation_string":"Department of Hemato-Oncology, Centre Hospitalier du Luxembourg, Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I162487826"]},{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091343254","display_name":"Bassam Janji","orcid":"https://orcid.org/0000-0002-9763-0943","observed_orcids":["https://orcid.org/0000-0002-9763-0943"]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":true,"raw_author_name":"Bassam Janji","raw_affiliation_strings":["Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg"],"raw_orcid":"https://orcid.org/0000-0002-9763-0943","affiliations":[{"raw_affiliation_string":"Tumor Immunotherapy and Microenvironment Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg City, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5042997291","https://openalex.org/A5091343254"],"corresponding_institution_ids":["https://openalex.org/I162487826","https://openalex.org/I4210101141"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":16.2472,"has_fulltext":false,"cited_by_count":262,"citation_normalized_percentile":{"value":0.99473723,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"6","issue":"18","first_page":"eaax7881","last_page":"eaax7881"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6000000238418579},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.8809999823570251},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ccl5","display_name":"RANTES","score":0.7960000038146973},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":1.0},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.753000020980835},{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.9909999966621399},{"id":"https://openalex.org/keywords/irf7","display_name":"IRF7","score":0.9919999837875366},{"id":"https://openalex.org/keywords/proinflammatory-chemokines","display_name":"inflammatory chemokines","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7397968769073486},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7026346921920776},{"id":"https://openalex.org/C116484652","wikidata":"https://www.wikidata.org/wiki/Q3492926","display_name":"CCL5","level":5,"score":0.6580474376678467},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6303853988647461},{"id":"https://openalex.org/C5858377","wikidata":"https://www.wikidata.org/wiki/Q986112","display_name":"CXCL10","level":4,"score":0.6141363978385925},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5791730880737305},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5729437470436096},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.517041027545929},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5091738104820251},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.48348480463027954},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41427624225616455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3901885449886322},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3493233323097229},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3065106272697449},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.279361367225647},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.20779123902320862},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.09195581078529358},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.08574172854423523},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07715925574302673},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1126/sciadv.aax7881","doi":"https://doi.org/10.1126/sciadv.aax7881","is_oa":true,"landing_page_url":"https://doi.org/10.1126/sciadv.aax7881","pdf_url":"https://advances.sciencemag.org/content/advances/6/18/eaax7881.full.pdf","source":{"id":"https://openalex.org/S2737427234","display_name":"Science Advances","issn_l":"2375-2548","issn":["2375-2548"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7190323","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7190323","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Adv","raw_type":"Text"},{"id":"pmid:32494661","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32494661","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1126/sciadv.aax7881","doi":"https://doi.org/10.1126/sciadv.aax7881","is_oa":true,"landing_page_url":"https://doi.org/10.1126/sciadv.aax7881","pdf_url":"https://advances.sciencemag.org/content/advances/6/18/eaax7881.full.pdf","source":{"id":"https://openalex.org/S2737427234","display_name":"Science Advances","issn_l":"2375-2548","issn":["2375-2548"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2859120143","display_name":"Targeted Therapies in Melanoma","funder_award_id":"P01CA114046","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3021675475.pdf"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1667863538","https://openalex.org/W1977841275","https://openalex.org/W1978172515","https://openalex.org/W1985124617","https://openalex.org/W2005202415","https://openalex.org/W2012958260","https://openalex.org/W2026861011","https://openalex.org/W2030058743","https://openalex.org/W2039123767","https://openalex.org/W2047341797","https://openalex.org/W2049173806","https://openalex.org/W2052618262","https://openalex.org/W2079130597","https://openalex.org/W2080689345","https://openalex.org/W2081796577","https://openalex.org/W2085846138","https://openalex.org/W2091729639","https://openalex.org/W2102690338","https://openalex.org/W2112601576","https://openalex.org/W2149360266","https://openalex.org/W2151713424","https://openalex.org/W2162222767","https://openalex.org/W2257916459","https://openalex.org/W2294356527","https://openalex.org/W2338576144","https://openalex.org/W2340636398","https://openalex.org/W2398131194","https://openalex.org/W2535234134","https://openalex.org/W2612370573","https://openalex.org/W2615994102","https://openalex.org/W2617691667","https://openalex.org/W2621587943","https://openalex.org/W2746563129","https://openalex.org/W2766463091","https://openalex.org/W2783887386","https://openalex.org/W2883840401","https://openalex.org/W2890923034","https://openalex.org/W2892082076","https://openalex.org/W2901014197","https://openalex.org/W2937057550"],"related_works":["https://openalex.org/W3081656916","https://openalex.org/W3083492229","https://openalex.org/W4282958710","https://openalex.org/W4282945294","https://openalex.org/W4404451126","https://openalex.org/W4414380527","https://openalex.org/W2112601576","https://openalex.org/W2811001941","https://openalex.org/W2982372328","https://openalex.org/W2797213570"],"abstract_inverted_index":{"T":[0,16],"effector":[1],"cells":[2],"in":[3,11,40,55],"melanoma":[4,56],"and":[5,27,31,37,45,57,59],"CRC":[6,58],"tumors.":[7],"Such":[8],"infiltration":[9],"resulted":[10],"the":[12,22,41,50,77],"establishment":[13],"of":[14,24,43,53,79],"a":[15],"cell-inflamed":[17],"tumor":[18],"microenvironment,":[19],"characterized":[20],"by":[21],"up-regulation":[23,42],"pro-inflammatory":[25],"chemokines":[26],"cytokines,":[28],"CCL5,":[29],"CXCL10,":[30],"IFN\u03b3.":[32],"Vps34i":[33,48],"treatment":[34],"induced":[35],"STAT1":[36],"IRF7,":[38],"involved":[39],"CCL5":[44],"CXCL10.":[46],"Combining":[47],"improved":[49],"therapeutic":[51],"benefit":[52],"anti-PD-L1/PD-1":[54,80],"prolonged":[60],"mice":[61],"survival.":[62],"Our":[63],"study":[64],"revealed":[65],"that":[66],"targeting":[67],"Vps34":[68],"turns":[69],"cold":[70],"into":[71],"hot":[72],"inflamed":[73],"tumors,":[74],"thus":[75],"enhancing":[76],"efficacy":[78],"blockade.":[81]},"counts_by_year":[{"year":2026,"cited_by_count":28},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":49},{"year":2023,"cited_by_count":49},{"year":2022,"cited_by_count":55},{"year":2021,"cited_by_count":39},{"year":2020,"cited_by_count":15}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-05-13T00:00:00"}